You can now read 5 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

Mass. Mover

Aveo Oncology seeks FDA approval for kidney cancer drug

Aveo currently has more than 300 employees.


Aveo currently has more than 300 employees.

Continue reading below

Aveo Oncology has submitted a new drug application to the Food and Drug Administration for a potential treatment for advanced kidney cancer. The Cambridge company has a deal with Japanese drug maker Astellas Pharma Inc. to commercialize tivozanib in some other countries. The application asks the FDA for approval to market tivozanib in the United States for patients with advanced renal cell carcinoma. An estimated 250,000 people are diagnosed with kidney cancer annually.

Loading comments...
Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
Please enter a valid email will never post anything without asking.
Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of